Muralitharan Kengatharan
-
- Immune Response and Inflammation 2
- Microbiology top 10%
- Ophthalmology top 10%
- Retinal Diseases and Treatments 3
- Glaucoma and retinal disorders 2
-
- Nitric Oxide and Endothelin Effects 4
-
- Neurological Disorders and Treatments 1
- Vagus Nerve Stimulation Research 1
-
- Advanced Breast Cancer Therapies 1
-
- Retinal Development and Disorders 1
- Co-authors
- Christoph ThiemermannSjef J. de KimpeJohn R. VaneJohn P. CookePeter A. CampochiaroKatsuji KiuchiRaquel Lima e SilvaMasato Matsuoka
- Cited by
- ImmunologyMicrobiologyOphthalmology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)British Journal of Pharmacology (2 papers)American Journal of Ophthalmology (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Muralitharan Kengatharan
9 papers receiving 445 citations
Peers
Comparison fields: 5 of 77
- Immunology 203
- Microbiology 56
- Ophthalmology 51
- Infectious Diseases 60
- Critical Care and Intensive Care Medicine 16
Countries citing papers authored by Muralitharan Kengatharan
This map shows the geographic impact of Muralitharan Kengatharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muralitharan Kengatharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muralitharan Kengatharan more than expected).
Fields of papers citing papers by Muralitharan Kengatharan
This network shows the impact of papers produced by Muralitharan Kengatharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muralitharan Kengatharan. The network helps show where Muralitharan Kengatharan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Muralitharan Kengatharan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS907 in Normotensive Cynomolgus Monkeys | 2011 | 1 |
| 2 | Pharmaceutical Profile of a Novel Rho Kinase (ROCK) inhibitor ATS8535 for Reduction of IOP in Glaucoma | 2011 | 3 |
| 3 | 2010 | 22 | |
| 4 | 2008 | 42 | |
| 5 | Nicotinic Receptor Antagonist Mecamylamine Reduces Laser-Induced Choroidal Neovascularization in C57bl/6j Mice | 2007 | 1 |
| 6 | 2001 | 22 | |
| 7 | 1996 | 74 | |
| 8 | 1995 | 4 | |
| 9 | 1995 | 283 |
About Muralitharan Kengatharan
Muralitharan Kengatharan is a scholar working on Ophthalmology, Neurology and Biophysics, having authored 9 papers that have together received 452 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (4 papers), Retinal Diseases and Treatments (3 papers), Immune Response and Inflammation (2 papers), Glaucoma and retinal disorders (2 papers), Neurological Disorders and Treatments (1 paper), Advanced Breast Cancer Therapies (1 paper), Retinal Development and Disorders (1 paper) and Vagus Nerve Stimulation Research (1 paper). The work is most often cited by research in Immunology (203 citations), Microbiology (56 citations) and Ophthalmology (51 citations). Muralitharan Kengatharan has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Christoph Thiemermann, Sjef J. de Kimpe, John R. Vane, John P. Cooke, Peter A. Campochiaro, Katsuji Kiuchi, Raquel Lima e Silva, Masato Matsuoka, Jenny Wu and Naw Htee Khu. Their work appears in journals such as Proceedings of the National Academy of Sciences, British Journal of Pharmacology and American Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.